全文获取类型
收费全文 | 13613篇 |
免费 | 578篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 310篇 |
儿科学 | 484篇 |
妇产科学 | 516篇 |
基础医学 | 1455篇 |
口腔科学 | 204篇 |
临床医学 | 1015篇 |
内科学 | 2719篇 |
皮肤病学 | 481篇 |
神经病学 | 953篇 |
特种医学 | 658篇 |
外国民族医学 | 1篇 |
外科学 | 2768篇 |
综合类 | 121篇 |
一般理论 | 2篇 |
预防医学 | 860篇 |
眼科学 | 368篇 |
药学 | 423篇 |
中国医学 | 36篇 |
肿瘤学 | 843篇 |
出版年
2023年 | 40篇 |
2022年 | 53篇 |
2021年 | 135篇 |
2020年 | 100篇 |
2019年 | 133篇 |
2018年 | 168篇 |
2017年 | 134篇 |
2016年 | 157篇 |
2015年 | 667篇 |
2014年 | 755篇 |
2013年 | 828篇 |
2012年 | 1033篇 |
2011年 | 962篇 |
2010年 | 837篇 |
2009年 | 812篇 |
2008年 | 992篇 |
2007年 | 950篇 |
2006年 | 969篇 |
2005年 | 830篇 |
2004年 | 703篇 |
2003年 | 452篇 |
2002年 | 397篇 |
2001年 | 150篇 |
2000年 | 117篇 |
1999年 | 116篇 |
1998年 | 127篇 |
1997年 | 126篇 |
1996年 | 111篇 |
1995年 | 107篇 |
1994年 | 73篇 |
1993年 | 86篇 |
1992年 | 57篇 |
1991年 | 68篇 |
1990年 | 63篇 |
1989年 | 56篇 |
1988年 | 53篇 |
1987年 | 46篇 |
1986年 | 59篇 |
1985年 | 57篇 |
1984年 | 44篇 |
1983年 | 66篇 |
1982年 | 53篇 |
1981年 | 48篇 |
1980年 | 50篇 |
1979年 | 47篇 |
1978年 | 26篇 |
1976年 | 24篇 |
1975年 | 23篇 |
1974年 | 27篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
1.
Cromb Amandine Le Loarer Franois Sitbon Maxime Italiano Antoine Stoeckle Eberhard Buy Xavier Kind Michle 《European radiology》2020,30(5):2413-2424
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification... 相似文献
2.
3.
4.
Well‐being,health and fitness of children who use wheelchairs: Feasibility study protocol to develop child‐centred ‘keep‐fit’ exercise interventions
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
6.
7.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
8.
9.
Chronic transplant dysfunction is a complex dynamic pathogenic process. Clinically, a decrease in glomerular filtration rate (GFR) becomes apparent leading to chronic renal insufficiency and dialysis or death from cardiovascular events. Chronic transplant dysfunction can develop into a chronic alIograft nephropathy (CAN) as a specific entity with dynamic progression. CAN includes a collection of immunologic and non-immunologic factors, rejection, ischemia time, donor and recipient characteristics and toxicity of calcineurin inhibitors. Despite improvements in immunosuppression, the long-range prognosis of renal allografts has not improved. Whether modern immunosuppressive concepts with reduction or avoidance of calcineurin inhibitors and a therapy based on antimetabolites, such as mycophenolate or mTOR-inhibitors could lead to a prolongation of transplant survival, remains to be seen. 相似文献
10.